Fairchem Organics Posts a Painful FY26 Revenue Falls 14% and PAT Drops 75%

Synopsis:- Fairchem Organics reported a meaningful Q4 recovery, with quarterly profit rebounding to Rs. 37 crore from near breakeven in Q3, and declared a Rs. 1 per share dividend for FY26.

Shares of the Ahmedabad-based speciality chemicals maker drew attention on Wednesday after its board approved audited results for FY2025–26, disclosing a year that illustrated just how vulnerable oleo chemical manufacturers remain to commodity pricing cycles. Revenue contracted sharply as realisation per tonne fell across the company’s key product categories, even as raw material costs held relatively firm.

With a market capitalisation of approximately Rs. 806.14 crore, the shares of Fairchem Organics Ltd. were trading at Rs. 640 per share as of May 4, 2026, up approximately 8.18 percent from a previous close near Rs. 591.6 apiece. The stock is trading at a P/E of approximately 305.10.

Fairchem Organics’ revenue from operations for FY2025–26 came in at Rs. 459.6 crore, down from Rs. 537.9 crore in FY2024–25,  a decline of roughly 14.5 percent. Net profit fell sharply to Rs. 5.54 crore from Rs. 21.97 crore in the prior year, a contraction of nearly 75 percent. The profit before tax for the full year stood at Rs. 73.2 crore against Rs. 299.2 crore , a 75.5 percent drop, with margins squeezed from multiple directions simultaneously.

Cost of materials consumed fell to Rs. 374.2 crore from Rs. 419.7 crore, which looks like relief on paper, but total expenses declined only to Rs. 452.7 crore from Rs. 509.3 crore, implying limited operating leverage on the way down. More damaging was the power and fuel line: at Rs. 23.1 crore for the year, it contracted from an elevated Rs. 35.2 crore in FY25, though Q4 alone saw power costs jump to Rs. 6 crore, nearly double Q3’s Rs. 3.9 crore, suggesting input cost volatility remains a live risk into FY27.

The company also recognised an exceptional charge of Rs. 88.3 lakh relating to incremental employee benefit obligations under the newly notified Labour Codes, which ate into Q3 profitability and contributed to the near-breakeven position that quarter.

The Q4 recovery is the only bright spot: revenue came in at Rs. 116.9 crore for the March quarter against Rs. 120.8 crore in Q4 FY25, while profit after tax recovered sharply to Rs. 3.69 crore from Rs. 0.59 crore in the year-ago quarter aided by a significant inventory drawdown benefit that reversed the Q3 build-up.

The board recommended a dividend of Rs. 1 per share, a 10 per cent payout on the Rs. 10 face value for FY2025–26, subject to shareholder approval at the 7th AGM scheduled for July 27, 2026. The record date for dividend entitlement has been fixed as July 20, 2026.

The Rs. 1 payout compares starkly with a Rs. 7.50 per share dividend declared for FY2024–25, underscoring how far earnings compression has translated into reduced shareholder distributions. However, it is worth noting that the company completed a buyback of 4,25,000 equity shares at Rs. 800 per share in January 2026, returning approximately Rs. 34 crore to shareholders through that route. The post-buyback paid-up share capital stands at 1,25,95,902 shares of Rs. 10 each, a reduction from 1,30,20,902 shares before the buyback.

Business Overview

Fairchem Organics Limited was incorporated in 2019 following the demerger of the oleo chemicals and nutraceuticals businesses from Fairchem Speciality Limited. The company manufactures speciality chemicals, including Dimer Acid, Linoleic Acid, Isostearic Acid, mixed tocopherol concentrates, and sterol concentrates at its plant in Village Chekhala, Sanand, Gujarat.

The company’s manufacturing model is built around procuring waste generated in oil refining mills and using processing equipment to isolate and purify components, some of which are further converted into value-added products like Dimer Acid. It is one of the few domestic manufacturers of both Linoleic Acid and Dimer Acid in India, giving it a degree of import substitution positioning.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.inare their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Fairchem Organics Posts a Painful FY26 Revenue Falls 14% and PAT Drops 75% appeared first on Trade Brains.